Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma

Leggi l'articolo originale


This narrative review discusses the rationale and results of clinical trials in immunotherapy-based combination therapy for patients with advanced renal cell carcinoma.

Lascia un commento